Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Blood Product
55%
Monospecific Antibody
55%
Seroprevalence
46%
COVID-19
44%
Mortality Rate
33%
Age
31%
Immunoglobulin G
23%
Hepatitis E Virus
22%
Time
21%
Sample
17%
Prevalence
16%
ELISA
16%
Seropositivity
15%
Comorbidity
13%
Infliximab
11%
Neutralization
10%
Immunoglobulin G Antibody
8%
Neovison Vison
8%
Azathioprine
8%
Blood Plasma
8%
Viral Disease
8%
Immunoglobulin M
7%
Intravenous Immunoglobulin
6%
Polymerase Chain Reaction
6%
Cells
6%
Immunity
6%
Immunoglobulin M Antibody
5%
Titer
5%
Genotype
5%
Pig
5%
ABO Blood Group System
5%
Blood Group
5%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
59%
Infection
50%
Antibody
36%
Blood Donor
35%
COVID-19
33%
Donor
30%
Immunoglobulin G
23%
Hepatitis E Virus
22%
Mortality Rate
20%
Assay
17%
Adverse Event
14%
RNA
13%
Prevalence
13%
Patient
13%
Seroprevalence
12%
Comorbidity
11%
Infliximab
11%
Age
9%
Enzyme Linked Immunosorbent Assay
8%
Azathioprine
8%
Corticosteroid
8%
Plasma
8%
Homelessness
7%
Immunoglobulin M
7%
Immunoassay
6%
Pneumonia
6%
Polymerase Chain Reaction
6%
Male
6%
Alertness
6%
Assessment
6%
Premedication
5%
Virus RNA
5%
Blood Group
5%
Blood Group ABO System
5%
Reinfection
5%
Genotype
5%
Nursing and Health Professions
Blood Donor
22%
Patient
21%
Infection
18%
Donor
16%
Confidence Interval
14%
Antibody
14%
Transfusion
13%
RNA
13%
Prevalence
10%
Adverse Event
8%
Physician
8%
Sample
6%
Polymerase Chain Reaction
6%
Immunoassay
5%
Reinfection
5%
Blood Group ABO System
5%
